Pathstone Family Office’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,500
Closed -$6K 1135
2022
Q1
$6K Buy
+2,500
New +$205K ﹤0.01% 960

Other funds holding THC

Pathstone Family Office's THC Position: Q3 2023 in Review

Pathstone Family Office increased its Tenet Healthcare (THC) stake by 90% in Q3 2023, buying an estimated $155K and bringing the position to 4,374 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Pathstone Family Office first reported a position in THC in Q2 2013 and has held it in 9 quarters since. The position peaked at $376K in Q1 2022. 408 funds tracked by Wall St. Rank hold THC as of Q3 2023.

  • Pathstone Family Office held 4,374 shares of Tenet Healthcare worth $288K as of Q3 2023.
  • Pathstone Family Office bought 2,076 Tenet Healthcare shares in Q3 2023, an estimated $155K.
  • Tenet Healthcare made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1337 holding.
  • Pathstone Family Office first reported a position in Tenet Healthcare in Q2 2013 and has held it in 9 quarters since.
  • Pathstone Family Office's Tenet Healthcare position peaked at $376K in Q1 2022.
  • 408 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.